OSA - OHS Overlap: Definition, Complications, and Management

What is OSA-OHS Overlap?

1. Obesity (BMI ≥ 30 kg/m²)
2. Daytime hypercapnia (awake PaCO₂ ≥ 45 mmHg)
3. Sleep-disordered breathing, after excluding other causes of alveolar hypoventilation (COPD, kyphoscoliosis, neuromuscular disease, opioids, sedative-hypnotics)

Pathophysiology of the Overlap

1. Abnormal respiratory mechanics - Reduced chest wall and respiratory system compliance, increased airway resistance, expiratory flow limitation, intrinsic PEEP, and reduced respiratory muscle efficiency from abdominal fat load.
2. Sleep-disordered breathing (OSA) - During apneic and hypopneic events, CO₂ loads accumulate. If the inter-event compensatory hyperventilation is inadequate, kidneys retain bicarbonate to buffer the transient pH drop. This retained bicarbonate progressively blunts the central hypercapnic ventilatory response (HCVR), creating a vicious cycle of worsening hypercapnia.
3. Blunted central ventilatory drive - Central hypothalamic resistance to leptin (a respiratory stimulant produced by adipose tissue) further reduces the drive to breathe. - Fishman's Pulmonary Diseases and Disorders, p. 1787

Clinical Presentation

Complications

Cardiovascular

• Pulmonary hypertension - More common and more severe than in either OSA or OHS alone; severe pulmonary hypertension is uncommon in pure OSA
• Cor pulmonale - Right heart failure resulting from pulmonary hypertension
• Systemic hypertension
• Congestive heart failure (biventricular)
• Angina / ischemic heart disease

Respiratory

• Acute-on-chronic hypercapnic respiratory failure - Patients often present to the ICU in decompensated state; this is frequently the first presentation that leads to diagnosis
• Polycythemia - From chronic nocturnal hypoxemia stimulating erythropoiesis
• Recurrent hospitalizations - Healthcare utilization is significantly elevated up to 5 years before OHS is even diagnosed

Metabolic

• Type 2 diabetes, metabolic syndrome - Obesity-driven comorbidities amplified by sleep fragmentation and hypoxemia

Mortality

• 2-year all-cause mortality of 23% in hospitalized patients with OHS (vs. 9% in simple obesity)
• 1-year mortality of 18% following acute hypercapnic respiratory failure admission
• One study of 600 OHS patients found 15% died on the index visit and another 16% died over 3 years of follow-up - Rosen's Emergency Medicine, p. 3501
• Untreated overlap syndrome has a relative mortality risk of 1.79 (95% CI 1.16-2.77) compared to COPD alone - Fishman's Pulmonary Diseases and Disorders, p. 1789

Diagnosis

• Serum bicarbonate is the initial screening test for patients with low-moderate pretest probability of OHS
• Serum HCO₃ < 27 mEq/L dramatically decreases the probability of OHS (sensitivity 92%)
• HCO₃ ≥ 27 mEq/L or high clinical suspicion → proceed to arterial blood gas (ABG)

• ABG showing PaCO₂ ≥ 45 mmHg while awake on room air, in the setting of BMI ≥ 30, with sleep-disordered breathing confirmed on polysomnography

Management

Step 1: Positive Airway Pressure (PAP) - First-Line

• Effective in 80% of patients with combined OSA-OHS - Murray & Nadel's Textbook of Respiratory Medicine
• Eliminates upper airway obstruction as the primary driver of CO₂ retention
• Improves daytime hypercapnia and hypoxemia in >50% of patients
• Use objectively monitored CPAP adherence to confirm response

• Reassess serum bicarbonate or ABG after several weeks of CPAP with documented adherence
• Normalization of serum HCO₃ or PaCO₂ confirms adequate treatment

Step 2: BiPAP (Bilevel PAP) - If CPAP Fails

• Patient cannot tolerate high CPAP pressures required
• Residual obstructive events persist at maximum CPAP (20 cmH₂O)
• Ongoing hypercapnia despite adequate CPAP adherence after 3 months

Step 3: BiPAP-ST or VAPS - Backup Rate Modes

• Reduced respiratory drive results in inadequate minute ventilation on BiPAP-S
• No improvement or worsening CO₂ on BiPAP-S monitoring
• Malignant OHS phenotype (low AHI but severe hypercapnia, >50 kg/m² BMI)
• OHS without significant OSA (these patients should start at BiPAP-ST directly)
• Acute decompensated OHS requiring hospital admission

• Target Vt: 8-10 mL/kg ideal body weight
• Backup rate: ~2 breaths below the patient's spontaneous rate
• Prolong inspiratory time (Ti) to allow recruitment of atelectatic basilar segments
• EPAP set to abolish obstructive events; titrated to AHI severity - Murray & Nadel's Textbook of Respiratory Medicine, pp. 2831

Step 4: Weight Loss and Bariatric Surgery

• Substantial weight loss (20-25% of actual body weight) alone can normalize PaCO₂
• Bariatric surgery is recommended by the American Thoracic Society guideline for eligible patients
• Achieving this degree of weight loss without surgery is very challenging

Step 5: Supplemental Oxygen

• Supplemental O₂ alone is not appropriate as primary treatment for OSA-OHS - PAP therapy is needed
• Long-term oxygen therapy (LTOT) may be added adjunctively in patients with refractory hypoxemia but should not replace NIPPV - Fishman's Pulmonary Diseases and Disorders, p. 3706

Summary Treatment Algorithm

OSA-OHS overlap confirmed (AHI ≥ 30 + PaCO₂ ≥ 45)
        │
        ▼
   Start CPAP → Reassess in 3 months (adherence + ABG/HCO₃)
        │
   ┌────┴────────────────────┐
 Resolved              Persistent hypercapnia
 (80% of cases)               │
                         Escalate to BiPAP-S
                              │
                    Still hypercapnic or low MV?
                              │
                    BiPAP-ST or VAPS (backup rate)
                              │
                    All patients: weight loss counseling
                    + bariatric surgery evaluation

Pharmacologic Agents

Key Takeaways

AHI (Apnea-Hypopnea Index)

Definition

What Counts as an AHI Event?

1. Apnea

• Drop in peak respiratory signal ≥ 90% from baseline
• Duration ≥ 10 seconds
• No oxygen desaturation or arousal is required to score an apnea

2. Hypopnea

• Airflow reduction ≥ 30% from baseline lasting ≥ 10 seconds
• PLUS either:
  • ≥ 3-4% drop in SpO₂ (oxygen desaturation), OR
  • An arousal from sleep on EEG

Note: The AASM accepts a 3% SpO₂ drop or an arousal; some bodies (e.g., Medicare) use 4%. This difference in definition significantly affects reported disease prevalence. - Fishman's Pulmonary Diseases and Disorders, p. 1731

Related Index - RDI (Respiratory Disturbance Index)

AHI Severity Classification

• Miller's Anesthesia, 10e; Fishman's Pulmonary Diseases and Disorders

• AHI ≥ 5 events/hour on polysomnography (PSG), with obstructive or mixed events >50% of total
• PLUS symptoms (excessive daytime sleepiness, unrefreshing sleep, fatigue), OR
• AHI ≥ 15 events/hour regardless of symptoms

REI - Home Sleep Testing Variant

Why AHI Has Limitations

• It does not capture the depth or duration of hypoxemia per event
• A patient with 20 short apneas with mild desaturation may have a higher AHI than a patient with 10 long apneas with severe desaturation - yet the latter may have greater cardiovascular risk
• Recent evidence shows "hypoxic burden" (area under the desaturation curve during respiratory events) is a stronger predictor of cardiovascular mortality than AHI alone - Fishman's Pulmonary Diseases and Disorders, p. 1732

Quick Summary